Figure 2
Plasma concentrations. Mean ± SD plasma concentrations of lumiliximab (A) and rituximab (B) during cycles 1, 3, and 6 of treatment for patients who received 500 mg/m2 of lumiliximab.
Plasma concentrations. Mean ± SD plasma concentrations of lumiliximab (A) and rituximab (B) during cycles 1, 3, and 6 of treatment for patients who received 500 mg/m2 of lumiliximab.
